Cannabis and Neuropsychological Functioning: An Update on Adverse Effects in Adolescence and Beyond

apa-logo_white_screenThe International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content.
Educational Objectives
  1. Discuss the magnitude of neuropsychological deficits associated with cannabis use
  2. Describe neuropsychological domains most affected by cannabis use
  3. List factors that may moderate adverse effects of cannabis
  4. Describe future research design considerations to further knowledge in this area

Course Information
Target Audience:Intermediate
Availability:Date Available: 2020-12-03
You may obtain CE for this webinar at any time.
Offered for CEYes
CostMembers $20
Non-Members $30
Refund PolicyThis webinar is not eligible for refunds
CE Credits1.0

Abstract
Public sentiment and laws around the use of cannabis continue to become more permissive in the United States alongside a growing perception of effective medicinal applications. Yet, there is a robust literature documenting cannabis-associated worsening of neuropsychological functioning. What does the current scientific research suggest about the type and magnitude of neuropsychological side-effects from recreational and medical use of cannabis? How have results from meta-analyses and large longitudinal studies contributed to our current understanding? Are findings similar in adolescent and adult samples? What factors contribute to poorer or better neuropsychological outcomes? What future research is needed to understand who may be more vulnerable or resilient to adverse effects of cannabis on neuropsychological functioning. This seminar will provide an update of the scientific literature addressing the aforementioned questions.

Disclosures
None

Author(s)

  • Dr. Raul Gonzalez is professor of psychology, psychiatry, and immunology at Florida International University and director of the Substance Use and HIV Neuropsychology Lab. He is a faculty member of the Department of Psychology's Clinical Science and Cognitive Neuroscience programs and is affiliated with the Center for Children and Families and the Center for Imaging Science.

    Dr. Gonzalez graduated with his PhD in Clinical Psychology from the San Diego State University / University of California, San Diego Joint Doctoral Program, where he specialized in Clinical Neuropsychology. He has approximately 20 years of experience conducting research on neurocognitive contributors and consequences of substance use and addiction, with a focus on cannabis. Most has been funded by the National Institutes on Drug Abuse.

    Through his research, Dr. Gonzalez aims to identify neurocognitive differences that may place individuals at risk for substance use disorders or that emerge from their use. He is currently the site co-principal investigator of the Adolescent Brain Cognitive Development study: a landmark project that brings together scientists and clinicians from across the United States with a broad range of knowledge and expertise to enroll 11,000+ healthy children and follow them from age 9-10 into early adulthood in order to better understand biological and environmental contributors healthy development, including risk factors and consequences for substance use disorders.



Watch Webinar

Webinar Home